Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Initial therapy for hypertension--individualizing care.

G L Schwartz1

  • 1Division of Hypertension and Internal Medicine, Mayo Clinic, Rochester, MN.

Mayo Clinic Proceedings
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order.

Clinical pharmacology and therapeutics·2009
Same author

Multilocus effects of the renin-angiotensin-aldosterone system genes on blood pressure response to a thiazide diuretic.

The pharmacogenomics journal·2004
Same author

Step care therapy for hypertension in diabetic patients.

Mayo Clinic proceedings·2002
Same author

Validity of the aldosterone-renin ratio used to screen for primary aldosteronism.

Mayo Clinic proceedings·2001
Same author

Use of gene markers to guide antihypertensive therapy.

Current hypertension reports·2001
Same author

Are aneroid sphygmomanometers accurate in hospital and clinic settings?

Archives of internal medicine·2001
Same journal

Thyroid Dysfunction and the Risk of Clinically Relevant Depression: A Longitudinal Cohort Study.

Mayo Clinic proceedings·2026
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
See all related articles

Treating mild hypertension is effective, but long-term patient compliance remains a challenge. Individualized treatment plans are crucial for managing this lifelong condition effectively.

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacology

Background:

  • Hypertension affects millions, with many having mild cases and low individual risk.
  • Large studies confirm the benefits of treating even mild hypertension.
  • Public health initiatives have improved awareness and treatment initiation for hypertension over 16 years.

Purpose of the Study:

  • To highlight the challenge of long-term patient adherence in hypertension management.
  • To emphasize the need for individualized treatment strategies.
  • To underscore the importance of understanding patient and treatment characteristics for compliance.

Main Methods:

  • Review of large group studies on hypertension treatment efficacy.
  • Analysis of public health efforts in hypertension awareness and treatment.

Related Experiment Videos

  • Examination of available nonpharmacologic and pharmacologic treatment options.
  • Main Results:

    • Mild hypertension, though low risk individually, benefits from treatment at a population level.
    • Significant progress has been made in identifying and initiating treatment for hypertensive patients.
    • Long-term patient compliance with therapy is a persistent and major challenge.

    Conclusions:

    • Individualized application of diverse therapeutic modalities is essential for hypertension management.
    • Enhancing benefit, minimizing harm, and increasing compliance require tailored treatment approaches.
    • A deep understanding of patient-specific factors and treatment options is key to lifelong hypertension management.